Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
Reducing food intake further in preparation for surgery can place unnecessary stress on the body at a time when strength and reserves matter most
BPC-157: A Quick Comparison for Context To further illustrate how WADA's list works, it's helpful to compare GHK-Cu to a peptide that is explicitly banned: BPC-157
Peptide therapy helps support and optimize the bodys natural processes
Melanotan peptide injections stimulate pigment cells, and its use has been linked to rapid changes in moles, including the potentially fatal skin cancer, melanoma
Injecting on or after a training day allows the post-injection window to overlap with a planned rest or lighter activity day, preserving training quality for the sessions that drive adaptation